Listas Anotadas de Medicamentos e Dispositivos
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| codeine | tablet | 15 mg (phosphate) | |
| codeine | tablet | 30 mg (phosphate) | |
| morphine | Injection | 10 mg (sulfate or hydrochloride) in 1-ml ampoule | |
| morphine | oral liquid | 10 mg (hydrochloride or sulfate)/5 ml | |
| morphine | tablet (prolonged release) | 10 mg (morphine sulfate) | |
| morphine | tablet (prolonged release) | 30 mg (morphine sulfate) | |
| morphine | tablet (prolonged release) | 60 mg (morphine sulfate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amoxicillin + clavulanic acid | tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
| azithromycin | oral liquid | 200 mg/5 mL | |
| azithromycin | tablet | 250 mg | |
| doxycycline | solid oral dosage form | 100 mg (as hydrochloride or hyclate) | |
| doxycycline | capsule | 100 mg (as hydrochloride or hyclate) | |
| sulfasalazine | tablet | 500 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| clofazimine | capsule | 50 mg | |
| clofazimine | capsule | 100 mg | |
| dapsone | tablet | 25 mg | |
| dapsone | tablet | 50 mg | |
| dapsone | tablet | 100 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amikacin | Powder for injection | 1 g (as sulfate) in vial | |
| capreomycin | Powder for injection | 1 g (as sulfate) in vial | |
| cycloserine | solid oral dosage form | 250 mg | |
| ethambutol | tablet | 100 mg to 400 mg (hydrochloride) | |
| ethambutol | oral liquid | 25 mg/ml | |
| ethambutol + isoniazid + pyrazinamide + rifampicin | tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
| ethambutol + isoniazid + rifampicin | tablet | 275 mg + 75 mg + 150 mg | |
| ethionamide | tablet | 125 mg | |
| ethionamide | tablet | 250 mg | |
| isoniazid | tablet | 100 mg to 300 mg | |
| isoniazid | tablet (scored) | 50 mg | |
| isoniazid + pyrazinamide + rifampicin | tablet | 75 mg + 400 mg + 150 mg | |
| isoniazid + pyrazinamide + rifampicin | tablet | 150 mg + 500 mg + 150 mg | |
| isoniazid + rifampicin | tablet | 75 mg + 150 mg | |
| isoniazid + rifampicin | tablet | 150 mg + 300 mg | |
| isoniazid + rifampicin | tablet | 60 mg + 60 mg | |
| isoniazid + rifampicin | tablet | 150 mg + 150 mg | |
| kanamycin | Powder for injection | 1 g (as sulfate) in vial | |
| levofloxacin | tablet | 250 mg | |
| levofloxacin | tablet | 500 mg | |
| ofloxacin | tablet | 200 mg | |
| ofloxacin | tablet | 400 mg | |
| p-aminosalicylate sodium (PAS sodium) | granules | 60% w/w in 100 gr container | |
| p-aminosalicylic acid | granules | 4 g in sachet | |
| p-aminosalicylic acid | tablet | 500 mg | |
| pyrazinamide | tablet | 400 mg | |
| pyrazinamide | tablet (scored) | 150 mg | |
| pyrazinamide | oral liquid | 30 mg/ml | |
| rifabutin | capsule | 150 mg | |
| rifampicin | solid oral dosage form | 150 mg | |
| rifampicin | solid oral dosage form | 300 mg | |
| rifampicin | oral liquid | 20 mg/ml | |
| streptomycin | Powder for injection | 1 g (as sulfate) in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amphotericin B | Powder for injection | 50 mg in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| abacavir (ABC) | tablet | 300 mg (as sulfate) | |
| abacavir (ABC) | oral liquid | 100 mg (as sulfate)/5 ml | |
| abacavir + lamivudine | tablet | 60 mg + 30 mg | |
| abacavir + lamivudine + zidovudine | tablet | 60 mg + 30 mg + 60 mg | |
| abacavir + lamivudine + zidovudine | tablet | 300 mg + 150 mg + 300 mg | |
| atazanavir | solid oral dosage form | 150 mg (as sulfate) | |
| atazanavir | solid oral dosage form | 300 mg (as sulfate) | |
| didanosine (ddI) | tablet (buffered chewable, dispersible) | 25 mg | |
| didanosine (ddI) | tablet (buffered chewable, dispersible) | 50 mg | |
| didanosine (ddI) | tablet (buffered chewable, dispersible) | 100 mg | |
| didanosine (ddI) | tablet (buffered chewable, dispersible) | 200 mg | |
| didanosine (ddI) | capsule (unbuffered enteric-coated) | 250 mg | |
| didanosine (ddI) | capsule (unbuffered enteric-coated) | 400 mg | |
| didanosine (ddI) | powder for oral liquid | 10mg/ml 2g | |
| efavirenz (EFV or EFZ) | capsule | 50 mg | |
| efavirenz (EFV or EFZ) | capsule | 200 mg | |
| efavirenz (EFV or EFZ) | tablet | 600 mg | |
| efavirenz + emtricitabine + tenofovir | tablet | 600 mg + 200 mg + 300 mg | |
| emtricitabine (FTC) | capsule | 200 mg | |
| emtricitabine + tenofovir | tablet | 200 mg + 300 mg | |
| indinavir (IDV) | solid oral dosage form | 400 mg (as sulfate) | |
| lamivudine (3TC) | tablet | 150 mg | |
| lamivudine (3TC) | oral liquid | 50 mg/5 ml | |
| lamivudine + nevirapine + stavudine | tablet (dispersible) | 30 mg + 50 mg + 6 mg | |
| lamivudine + nevirapine + stavudine | tablet (dispersible) | 60 mg + 100 mg + 12 mg | |
| lamivudine + nevirapine + stavudine | tablet | 150 mg + 200 mg + 30 mg | |
| lamivudine + nevirapine + zidovudine | tablet | 150 mg + 200 mg + 300 mg | |
| lamivudine + zidovudine | tablet | 150 mg + 300 mg | |
| lamivudine + zidovudine | tablet | 30 mg + 60 mg | |
| lopinavir + ritonavir (LPV/r) | tablet (heat stable) | 100 mg + 25 mg | |
| lopinavir + ritonavir (LPV/r) | tablet (heat stable) | 200 mg + 50 mg | |
| lopinavir + ritonavir (LPV/r) | oral liquid | 400 mg + 100 mg/5 ml | |
| nelfinavir | tablet | 250 mg | |
| nevirapine (NVP) | tablet | 200 mg | |
| nevirapine (NVP) | oral liquid | 50 mg/5 ml | |
| ritonavir | tablet (heat stable) | 100 mg | |
| saquinavir (SQV) | solid oral dosage form | 500 mg (as mesilate) | |
| stavudine (d4T) | capsule | 15 mg | |
| stavudine (d4T) | capsule | 20 mg | |
| stavudine (d4T) | capsule | 30 mg | |
| stavudine (d4T) | powder for oral liquid | 5 mg/5 ml | |
| stavudine + lamivudine | tablet | 30 mg + 150 mg | |
| tenofovir + lamivudine | capsule | 300 mg + 300 mg | |
| tenofovir disoproxil fumarate | tablet | 300 mg | |
| zidovudine (ZDV or AZT) | tablet | 300 mg | |
| zidovudine (ZDV or AZT) | capsule | 100 mg | |
| zidovudine (ZDV or AZT) | oral liquid | 50 mg/5 mL | |
| zidovudine (ZDV or AZT) | Solution for IV infusion injection | 10 mg/mL in 20-mL vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| aciclovir | Powder for injection | 250 mg (as sodium salt) in vial | |
| aciclovir | tablet | 200 mg | |
| oseltamivir | tablet | 75 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amphotericin B | Powder for injection | 50 mg in vial | |
| meglumine antimoniate | Solution for IV infusion injection | 85 mg/ml in ampoule | |
| paromomycin | solution for intramuscular injection | 750 mg of paromomycin base (as the sulfate) | |
| pentamidine | tablet | 200 mg (as isethionate) | |
| pentamidine | tablet | 300 mg (as isethionate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amodiaquine | tablet | 153 mg (as hydrochloride) | |
| amodiaquine | tablet | 200 mg (as hydrochloride) | |
| artemether | Oily injection | 80 mg/ml in 1-ml ampoule | |
| artemether + lumefantrine | tablet | 20 mg + 120 mg | |
| artesunate | tablet | 50 mg | |
| artesunate | Injection | ampoules, containing 60 mg anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution | |
| artesunate | rectal dosage form | 200 mg capsules | |
| artesunate + amodiaquine | tablet | 25 mg + 67.5 mg | |
| artesunate + amodiaquine | tablet | 50 mg + 135 mg | |
| artesunate + amodiaquine | tablet | 100 mg + 270 mg | |
| artesunate + mefloquine | tablet | 100 mg + 220 mg | |
| atovaquone + proguanil | tablet | 250 mg + 100 mg (as hydrochloride) | |
| atovaquone + proguanil | tablet | 62.5 mg + 25 mg (as hydrochloride) | c2 |
| chloroquine | oral liquid | 50 mg (as phosphate or sulfate)/5 ml | |
| chloroquine | tablet | 100 mg (as phosphate or sulfate) | |
| chloroquine | tablet | 150 mg (as phosphate or sulfate) | |
| mefloquine | tablet | 250 mg (hydrochloride) | |
| primaquine | tablet | 7.5 mg (as diphosphate) | |
| primaquine | tablet | 15 mg (as diphosphate) | |
| proguanil | tablet | 100 mg (as hydrochloride) | |
| quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule | |
| quinine | tablet | 300 mg (quinine sulfate) | |
| quinine | tablet | 300 mg (quinine bisulfate) | |
| sulfadoxine + pyrimethamine | tablet | 500 mg + 25 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| pentamidine | tablet | 200 mg (as isethionate) | |
| pentamidine | tablet | 300 mg (as isethionate) | |
| pyrimethamine | tablet | 25 mg | |
| sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 5-mL ampoule | |
| sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 10-mL ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| benznidazole | tablet | 100 mg | |
| nifurtimox | tablet | 120 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| albendazole | tablet (chewable) | 400 mg | |
| mebendazole | tablet (chewable) | 500 mg | |
| niclosamide | tablet (chewable) | 500 mg | |
| praziquantel | tablet | 150 mg | |
| praziquantel | tablet | 600 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| triclabendazole | tablet | 250 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| diethylcarbamazine | tablet | 50 mg (dihydrogen citrate) | |
| diethylcarbamazine | tablet | 100 mg (dihydrogen citrate) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| azathioprine | Powder for injection | 100 mg (as sodium salt) in vial | |
| azithromycin | powder for oral suspension | 200 mg | |
| ciclosporin | capsule | 25 mg | |
| ciclosporin | concentrate for injection | 50 mg/ml in 1-ml ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| asparaginase | Powder for injection | 10 000 IU in vial | |
| bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
| calcium folinate | Injection | 3 mg/mL in 10-mL ampoule | |
| calcium folinate | tablet | 15 mg | |
| chlorambucil | tablet | 2 mg | |
| cisplatin | Powder for injection | 10 mg in vial | |
| cisplatin | Powder for injection | 50 mg in vial | |
| cyclophosphamide | Powder for injection | 500 mg in vial | |
| cyclophosphamide | tablet | 25 mg | |
| cytarabine | Powder for injection | 100 mg in vial | |
| dacarbazine | Powder for injection | 100 mg in vial | |
| dactinomycin | Powder for injection | 500 mcg in vial | |
| daunorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
| doxorubicin | Powder for injection | 10 mg (hydrochloride) in vial | |
| doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
| etoposide | capsule | 100 mg | |
| etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
| mercaptopurine | tablet | 50 mg | |
| mesna | injectable solution | 400 mg | |
| methotrexate | Powder for injection | 50 mg (as sodium salt) in vial | |
| methotrexate | tablet | 2.5 mg (as sodium salt) | |
| procarbazine | capsule | 50 mg (as hydrochloride) | |
| tamoxifen | tablet | 10 mg (as citrate) | |
| tamoxifen | tablet | 20 mg (as citrate) | |
| vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
| vincristine | Powder for injection | 1 mg (sulfate) in vial | |
| vincristine | Powder for injection | 5 mg (sulfate) in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| factor IX complex (coagulation factors, II, VII, IX, X) concentrate | Dried | N/A | |
| factor VIII concentrate | Dried | N/A | |
| human normal immunoglobulin | intramuscular administration | 16% protein solution | |
| human normal immunoglobulin | intravenous administration | 5% protein solution | |
| human normal immunoglobulin | intravenous administration | 10% protein solution |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| anti-D immunoglobulin (human) | Injection | 250 mcg in single-dose vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| hydralazine | Powder for injection | 20 mg (hydrochloride) in ampoule | |
| hydralazine | tablet | 25 mg (hydrochloride) | |
| hydralazine | tablet | 50 mg (hydrochloride) | |
| sodium nitroprusside | Powder for infusion | 50 mg in ampoule | |
| surfactant | Suspension for intratracheal instillation | 25 mg/ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| glyceryl trinitrate | tablet (sublingual) | 500 mcg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| streptokinase | Powder for injection | 1.5 million IU in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amidotrizoate | Injection | 140 mg to 420 mg iodine (as sodium or meglumine salt)/ml in 20-ml ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| ethinylestradiol + levonorgestrel | tablet | 30 mcg + 150 mcg | |
| ethinylestradiol + norethisterone | tablet | 35 micrograms + 1 mg | |
| levonorgestrel | tablet | 30 micrograms | |
| levonorgestrel | tablet | 750 micrograms (pack of two) | |
| levonorgestrel | tablet | 1.5 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| estradiol cypionate + medroxyprogesterone acetate | Injection | 5 mg + 25 mg | |
| medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial | |
| norethisterone enantate | Oily solution | 200 mg/ml in 1-ml ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| insulin injection (soluble) | Injection | 40 IU/ml in 10-ml vial | |
| insulin injection (soluble) | Injection | 100 IU/ml in 10-ml vial | |
| intermediate-acting insulin | Injection | 40 IU/ml in 10-ml vial | |
| intermediate-acting insulin | Injection | 100 IU/ml in 10-ml vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| recombinant human erytropoietin | Injection | 2000-5000 UI/ml | |
| recombinant human erytropoietin | Injection | 20 000-50 000 UI/ml |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| dexamethasone | Injection | 4 mg/mL in 1-mL ampoule (as disodium phosphate salt) | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| alcuronium | Injection | 5 mg (chloride)/ml in 2ml ampoule | |
| vecuronium | Powder for injection | 10 mg (bromide)/mL in ampoule |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| carbamazepine | oral liquid | 100 mg/5 ml | |
| carbamazepine | tablet (chewable) | 100 mg | |
| carbamazepine | tablet (chewable) | 200 mg | |
| carbamazepine | tablet (scored) | 100 mg | |
| carbamazepine | tablet (scored) | 200 mg | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | rectal solution | 5 mg/mL in 2-mL tubes | |
| ergometrine | Injection | 200 micrograms (hydrogen maleate) in 1-ml ampoule | |
| magnesium sulfate | Injection | 500 mg/mL in 2-mL ampoule | |
| magnesium sulfate | Injection | 500 mg/mL in 10-mL ampoule | |
| mifepristone | tablet | 200 mg | |
| mifepristone + misoprostol | tablet | 200 mg + 200 micrograms | |
| misoprostol | tablet | 200 mcg | |
| oxytocin | Injection | 10 IU in 1-mL ampoule | |
| phenobarbital | Injection | 200 mg/mL (sodium) | |
| phenobarbital | oral liquid | 15 mg/5 mL | |
| phenobarbital | tablet | 15 mg to 100 mg | |
| phenytoin | solid oral dosage form | 25 mg (sodium salt) | |
| phenytoin | solid oral dosage form | 50 mg (sodium salt) | |
| phenytoin | solid oral dosage form | 100 mg (sodium salt) | |
| phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
| phenytoin | oral liquid | 25 mg to 30 mg/5 mL |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
| chlorpromazine | oral liquid | 25 mg (hydrochloride)/5 mL | |
| chlorpromazine | tablet | 100 mg (hydrochloride) | |
| fluphenazine | Injection | 25 mg (decanoate or enantate) in 1-mL ampoule | |
| haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
| haloperidol | tablet | 2 mg | |
| haloperidol | tablet | 5 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| amitriptyline | tablet | 25 mg (hydrochloride) | |
| fluoxetine | solid oral dosage form | 20 mg (as hydrochloride) |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| lithium carbonate | solid oral dosage form | 300 mg |
| Medicamento | Forma farmacêutica | Composição | Observações |
|---|---|---|---|
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule |